GO
Loading...

Innovation

More

  • Fat profits for Bacon Bowl     Thursday, 6 Mar 2014 | 8:57 AM ET

    Can the Bacon Bowl actually turn bacon into a bowl? CNBC's Jane Wells put the product to the test.

  • Shark Tank Herjavec's advice     Wednesday, 5 Mar 2014 | 2:58 PM ET

    "Shark Tank's" Robert Herjavec says people have to invest in something they understand.

  • Google moves into housing     Wednesday, 5 Mar 2014 | 1:20 PM ET

    CNBC's Diana Olick reports Google is making a huge investment in Auction.com, which is an auction-based real estate sales site for both residential and commercial real estate.

  • SpaceEx is lowering the cost of access to space exploration, says Steve Jurvetson, Tesla and SpaceX board member and managing partner at Draper Fisher Jurvetson, on the affordability of a "new-space period."

  • Whistle CEO: US pet market very large     Wednesday, 5 Mar 2014 | 10:49 AM ET

    Ben Jacobs, Whistle co-founder and CEO, discusses the demand for monitoring your dog's activity and energy exertion.

  • WASHINGTON, March 3- Concerns that cuts in defense spending could erode the U.S. military's technological edge over rivals such as Russia and China are in part driving the Pentagon's plans to slash troop levels and retire aging weapons.

  • CUPERTINO, Calif., Feb 28- Apple Inc sold more than $1 billion of Apple TV set-top boxes in 2013 and is investing heavily in the next generation of products, Chief Executive Tim Cook said at the company's annual meeting on Friday.

  • CNBC's Josh Lipton reports from the Apple shareholder meeting where Apple shareholders voted overwhelmingly to re-elect their board of directors.

  • Discussing why some companies choose to accept bitcoin, and if it's here to stay, with Quartz reporter Tim Fernholz.

  • Apple CEO Cook: We get ripped off enough     Friday, 28 Feb 2014 | 2:13 PM ET

    CNBC's Josh Lipton reports from the Apple shareholder meeting, where CEO Tim Cook fielded questions from shareholders and answered why the company does not talk about new products.

  • Apple morphing into trading stock: Analyst     Friday, 28 Feb 2014 | 11:35 AM ET

    "Apple is a very, very different kind of company," says Sanford C. Bernstein analyst Toni Sacconaghi, discussing recent trading action amid anticipation of new products.

  • Discussing Apple innovation and what products the tech giant plan on introducing next, with Bruce Tognazzini, Norman Nielsen Group principal.

  • Tesla to Texas: How do you like us now?     Friday, 28 Feb 2014 | 10:43 AM ET

    Bill Wolters, Texas Automobile Dealers Association president, discusses what it would mean to the state of Texas to land Tesla's "Gigafactory" and if it would change its law that bans Tesla from selling in the state. CNBC's Phil LeBeau provides.

  • Splunk CEO: Hacking is the new reality     Friday, 28 Feb 2014 | 10:37 AM ET

    You have to assume that you've been hacked, says Godfrey Sullivan, Splunk chairman & CEO, discussing cybersecurity technology.

  • Godfrey Sullivan, Splunk chairman & CEO, discusses whether he expects broad changes from Apple's Tim Cook today.

  • Apple needs new products: Analyst     Friday, 28 Feb 2014 | 10:05 AM ET

    Colin Gillis, director of research and senior technology analyst at BGC Financial, discusses what investors expect to hear from CEO Tim Cook at Apple's annual shareholder meeting. With CNBC Jon Fortt.

  • The opioid drug, manufactured by Zogenix Inc, contains a potent amount of an active ingredient that could be lethal to new patients and children and is not safer than other current pain drugs, the groups told the Food and Drug Administration. In December, attorneys general from 28 states also urged the FDA to reconsider its approval of the drug.

  • Tesla: An energy play or an auto play?     Thursday, 27 Feb 2014 | 3:27 PM ET

    CNBC's Phil LeBeau and Cole Wilcox of Longboard Asset Management debate what kind of company Tesla is and if investors should be paying such high premiums at this stage.

  • Groups urge FDA to halt launch of Zohydro pain drug Thursday, 27 Feb 2014 | 12:42 PM ET

    The opioid drug, manufactured by Zogenix Inc, contains a potent amount of an active ingredient that could be lethal to new patients and children and is not safer than other current pain drugs, the groups told the Food and Drug Administration. In December, attorneys general from 28 states also urged the FDA to reconsider its approval of the drug.

  • Tesla investing $2 billion in 'gigafactory'     Thursday, 27 Feb 2014 | 10:24 AM ET

    CNBC's Phil LeBeau reports on Tesla's plans to open a "gigafactory" to build battery packs. The facility would make the powerful and pricey lithium-ion batteries that power its Model S.